Anna C Barbano1, Willem F van der Mei1, Terri A deRoon-Cassini2, Ettie Grauer1, Sarah Ryan Lowe3, Yutaka J Matsuoka4, Meaghan O'Donnell5, Miranda Olff6,7, Wei Qi1, Andrew Ratanatharathorn8, Ulrich Schnyder9, Soraya Seedat10, Ronald C Kessler11, Karestan C Koenen12, Arieh Y Shalev1. 1. Department of Psychiatry, New York University School of Medicine, New York, New York. 2. Department of Surgery, Medical College of Wisconsin, Milwaukee, Wisconsin. 3. Department of Psychology, Montclair State University, Montclair, New Jersey. 4. Division of Health Care Research, Center for Public Health Sciences, National Cancer Center Japan, Tokyo, Japan. 5. Pheonix Australia, Department of Psychiatry, The University of Melbourne, Parkville, Australia. 6. Department of Psychiatry, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands. 7. Arq Psychotrauma Expert Group, Diemen, The Netherlands. 8. Department of Epidemiology, Columbia University Mailman School of Public Health, New York, New York. 9. Department of Psychiatry, University of Zurich, Zürich, Switzerland. 10. Department of Psychiatry, Stellenbosch University, Cape Town, South Africa. 11. Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts. 12. Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Abstract
OBJECTIVE: Posttraumatic stress disorder (PTSD) is frequently associated with depression and anxiety, but the nature of the relationship is unclear. By removing mood and anxiety diagnostic criteria, the 11th edition of the International Classification of Diseases (ICD-11) aims to delineate a distinct PTSD phenotype. We examined the effect of implementing ICD-11 criteria on rates of codiagnosed depression and anxiety in survivors with recent PTSD. METHOD: Participants were 1,061 survivors of traumatic injury admitted to acute care centers in Israel. ICD-10 and ICD-11 diagnostic rules were applied to the Clinician-Administered PTSD Scale for DSM-IV. Co-occurring disorders were identified using the Structured Clinical Interview for DSM-IV (SCID). Depression severity was measured by the Beck Depression Inventory-II (BDI-II). Assessments were performed 0-60 ("wave 1") and 90-240 ("wave 2") days after trauma exposure. RESULTS: Participants identified by ICD-11 PTSD criteria were equally or more likely than those identified by the ICD-10 alone to meet depression or anxiety disorder diagnostic criteria (for wave 1: depressive disorders, OR [odds ratio] = 1.98, 95% CI [confidence interval] = [1.36, 2.87]; anxiety disorders, OR = 1.04, 95% CI = [0.67, 1.64]; for wave 2: depressive disorders, OR = 1.70, 95% CI = [1.00, 2.91]; anxiety disorders, OR = 1.04, 95% CI = [0.54, 2.01]). ICD-11 PTSD was associated with higher BDI scores (M = 23.15 vs. 17.93, P < 0.001 for wave 1; M = 23.93 vs. 17.94, P < 0.001 for wave 2). PTSD symptom severity accounted for the higher levels of depression in ICD-11 PTSD. CONCLUSIONS: Despite excluding depression and anxiety symptom criteria, the ICD-11 identified equal or higher proportion of depression and anxiety disorders, suggesting that those are inherently associated with PTSD.
OBJECTIVE:Posttraumatic stress disorder (PTSD) is frequently associated with depression and anxiety, but the nature of the relationship is unclear. By removing mood and anxiety diagnostic criteria, the 11th edition of the International Classification of Diseases (ICD-11) aims to delineate a distinct PTSD phenotype. We examined the effect of implementing ICD-11 criteria on rates of codiagnosed depression and anxiety in survivors with recent PTSD. METHOD:Participants were 1,061 survivors of traumatic injury admitted to acute care centers in Israel. ICD-10 and ICD-11 diagnostic rules were applied to the Clinician-Administered PTSD Scale for DSM-IV. Co-occurring disorders were identified using the Structured Clinical Interview for DSM-IV (SCID). Depression severity was measured by the Beck Depression Inventory-II (BDI-II). Assessments were performed 0-60 ("wave 1") and 90-240 ("wave 2") days after trauma exposure. RESULTS:Participants identified by ICD-11 PTSD criteria were equally or more likely than those identified by the ICD-10 alone to meet depression or anxiety disorder diagnostic criteria (for wave 1: depressive disorders, OR [odds ratio] = 1.98, 95% CI [confidence interval] = [1.36, 2.87]; anxiety disorders, OR = 1.04, 95% CI = [0.67, 1.64]; for wave 2: depressive disorders, OR = 1.70, 95% CI = [1.00, 2.91]; anxiety disorders, OR = 1.04, 95% CI = [0.54, 2.01]). ICD-11 PTSD was associated with higher BDI scores (M = 23.15 vs. 17.93, P < 0.001 for wave 1; M = 23.93 vs. 17.94, P < 0.001 for wave 2). PTSD symptom severity accounted for the higher levels of depression in ICD-11 PTSD. CONCLUSIONS: Despite excluding depression and anxiety symptom criteria, the ICD-11 identified equal or higher proportion of depression and anxiety disorders, suggesting that those are inherently associated with PTSD.
Authors: Brianna M Byllesby; Jon D Elhai; Marijo Tamburrino; Thomas H Fine; Gregory Cohen; Laura Sampson; Edwin Shirley; Philip K Chan; Israel Liberzon; Sandro Galea; Joseph R Calabrese Journal: J Affect Disord Date: 2017-01-15 Impact factor: 4.839
Authors: Meaghan L O'Donnell; Nathan Alkemade; Angela Nickerson; Mark Creamer; Alexander C McFarlane; Derrick Silove; Richard A Bryant; David Forbes Journal: Br J Psychiatry Date: 2014-05-08 Impact factor: 9.319
Authors: Richard A Bryant; Meaghan L O'Donnell; Mark Creamer; Alexander C McFarlane; Derrick Silove Journal: JAMA Psychiatry Date: 2013-08 Impact factor: 21.596
Authors: Anna C Barbano; Willem F van der Mei; Richard A Bryant; Douglas L Delahanty; Terri A deRoon-Cassini; Yutaka J Matsuoka; Miranda Olff; Wei Qi; Andrew Ratanatharathorn; Ulrich Schnyder; Soraya Seedat; Ronald C Kessler; Karestan C Koenen; Arieh Y Shalev Journal: Psychol Med Date: 2018-05-14 Impact factor: 7.723
Authors: Abel S Mathew; Salahadin Lotfi; Kenneth P Bennett; Sadie E Larsen; Caron Dean; Christine L Larson; Han-Joo Lee Journal: J Behav Ther Exp Psychiatry Date: 2021-12-06
Authors: Rebecca B Lawn; Kristen M Nishimi; Yongjoo Kim; Sun Jae Jung; Andrea L Roberts; Jennifer A Sumner; Rebecca C Thurston; Lori B Chibnik; Eric B Rimm; Andrew D Ratanatharathorn; Shaili C Jha; Karestan C Koenen; Shelley S Tworoger; Laura D Kubzansky Journal: Cancer Epidemiol Biomarkers Prev Date: 2020-12-21 Impact factor: 4.254
Authors: Yara Mekawi; Madison W Silverstein; Aisha Walker; Martha Ishiekwene; Sierra Carter; Vasiliki Michopoulos; Jennifer S Stevens; Abigail Powers Journal: J Anxiety Disord Date: 2022-03-10
Authors: Yibin Ao; Hao Zhu; Fanrong Meng; Yan Wang; Gui Ye; Linchuan Yang; Na Dong; Igor Martek Journal: Int J Environ Res Public Health Date: 2020-12-06 Impact factor: 3.390
Authors: Patricia C Swart; Leigh L van den Heuvel; Cathryn M Lewis; Soraya Seedat; Sian M J Hemmings Journal: Front Neurosci Date: 2021-06-10 Impact factor: 4.677